Concepedia

Publication | Open Access

REDD1 is a determinant of low-dose metronomic doxorubicin-elicited endothelial cell dysfunction through downregulation of VEGFR-2/3 expression

15

Citations

35

References

2021

Year

References

YearCitations

Page 1